Abeona Therapeutics Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.4 | – | – | – | – | – | – | – | – | – | – | – | 4.9 | |
| 224.6 | 63.2 | 78.8 | 811.7 | 515.8 | 232.8 | 17.1 | 53.3 | 96.6 | – | 0.0 | 205.6 | 28.4 | 110.8 | 81.3 | 15.1 | 1.3 | 3.1 | 1.8 | 90.2 | 188.4 | 790.7 | 112.6 | – | 14.8 | 11.2 | 17.2 | 30.5 | – | 60.2 | |
| 9.2 | 45.9 | 4.4 | 3.4 | 3.7 | 6.2 | 40.2 | – | – | – | – | 17.2 | – | – | – | – | – | – | 0.4 | 1.4 | 1.7 | 3.9 | 2.5 | 0.9 | 1.4 | 0.8 | 0.9 | 7.2 | 5.2 | 2.2 | |
| 198.9 | 62.6 | 64.8 | 753.4 | 563.6 | 260.3 | 28.7 | 63.6 | 119.0 | – | 0.0 | 181.8 | 41.0 | 124.7 | 78.1 | 15.3 | 2.2 | 2.9 | -10.2 | 51.1 | 110.6 | 621.7 | 116.3 | – | 13.9 | 0.8 | 8.4 | 26.7 | – | 50.3 | |
| – | – | – | – | – | – | – | – | – | – | 7.7 | – | – | – | – | – | – | 1.3 | – | – | – | – | – | – | – | – | – | – | – | 3.7 | |
| – | – | – | – | – | – | – | – | – | – | – | 2.4 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -7.2% | -13.3% | -41.9% | -26.7% | -8.0% | -10.1% | -45.8% | -9.9% | -17.5% | -87.1% | -19.8% | 41.2% | -80.4% | -5.8% | -17.6% | -27.3% | -68.4% | 0.0% | -94.8% | -11.4% | -8.1% | -3.6% | -17.4% | -41.7% | -24.5% | -208.6% | -178.9% | -34.9% | -25.4% | -24.1% | |
| Margins | ||||||||||||||||||||||||||||||
| -4,878.4% | -33.3% | 100.0% | 100.0% | 100.0% | 100.0% | 90.7% | 78.6% | 56.5% | – | 100.0% | 100.0% | 100.0% | 100.0% | 70.9% | 34.2% | 93.9% | 93.9% | 100.0% | 100.0% | -1,098.5% | -1,929.7% | -1,190.8% | – | 100.0% | 100.0% | 68.2% | 54.1% | – | 73.7% | |
| -6,953.9% | -1,040.0% | -3,500.0% | -22,326.7% | -5,661.7% | -2,595.9% | -758.5% | -419.0% | -1,093.4% | – | -0.9% | -12,105.3% | -5,812.7% | -2,748.9% | -1,612.7% | -426.2% | -98.0% | -186.3% | -338.5% | -1,783.3% | -2,686.3% | -3,325.7% | -1,940.2% | – | -814.2% | -2,994.5% | -3,600.8% | -1,346.7% | – | -1,536.9% | |
| -6,863.5% | -1,020.9% | -3,400.0% | -22,053.3% | -5,072.9% | -2,480.2% | -818.1% | -535.5% | -1,864.8% | – | -2.3% | -38,147.4% | -10,801.0% | -4,926.1% | -1,566.9% | -137.0% | -239.1% | 217.9% | -2,894.9% | -1,396.7% | -2,460.4% | -3,263.9% | -1,890.3% | – | -842.3% | -2,831.2% | -2,807.4% | -1,548.2% | – | 1,223.1% | |
| -1,620.4% | -837.7% | -3,300.0% | -21,666.7% | -4,115.0% | -2,342.0% | -784.5% | -527.0% | -1,693.6% | – | -0.4% | 8,464.9% | -2,286.3% | -639.2% | -1,427.7% | -413.9% | -90.1% | 0.0% | -174.2% | -1,031.8% | -1,522.3% | -2,842.9% | -1,954.8% | – | -363.6% | -2,327.2% | -3,084.4% | -1,066.9% | – | -1,448.5% | |
| Returns | ||||||||||||||||||||||||||||||
| -282.3% | -741.4% | -188.9% | -91.9% | -36.2% | -66.4% | -1,919.0% | – | – | – | – | -3,193.0% | – | – | – | – | – | – | -556.0% | -21.4% | -22.1% | -16.1% | -42.3% | -42.8% | -82.1% | -200.5% | -148.3% | -365.5% | -144.7% | 44.7% | |
| -232.6% | -306.9% | -141.7% | -71.9% | -17.8% | -23.6% | -48.2% | -58.7% | -92.3% | -23.6% | -200.3% | -237.7% | -753.6% | -1,095.4% | -85.9% | -66.9% | -608.8% | 725.8% | -161.5% | -18.1% | -19.7% | -15.3% | -32.5% | -34.1% | -55.7% | -106.7% | -61.8% | -84.7% | -58.5% | 32.4% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||
| -4.3 | -0.3 | -1.4 | -0.9 | 5.1 | 6.7 | 13 | 13 | 12 | 7.4 | 13 | -1.4 | 3.6 | 4.9 | -1.5 | 0.3 | 3.7 | -0.4 | -11 | -41 | -69 | -141 | 11 | -128 | -9.1 | -31 | -12 | -13 | -3.6 | -58 | |
| – | – | – | – | – | – | – | – | – | – | 4.4 | – | – | – | – | – | – | -0.1 | – | – | – | – | – | – | – | – | – | – | – | -0.7 | |
| 82.4% | 41.4% | 75.0% | 78.3% | 49.2% | 35.6% | 2.5% | -49.3% | -60.1% | -58.7% | -153.9% | 7.4% | -268.2% | -1,704.9% | -237.1% | -465.2% | -987.1% | -2,410.9% | 29.0% | 84.6% | 89.2% | 95.2% | 76.9% | 79.9% | 67.8% | 53.2% | 41.7% | 23.2% | 40.4% | 72.5% | |
| 0.0 | 0.3 | 0.1 | 0.0 | 0.9 | 1.6 | 30.0 | – | – | – | – | 8.2 | – | – | – | – | – | – | 0.1 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.4 | 0.1 | |
| Per Share | ||||||||||||||||||||||||||||||
| -28,655.00 | -11,102.50 | -6,204.38 | -3,396.30 | -3,073.61 | -2,930.00 | -4,477.10 | -3,268.14 | -4,221.86 | -656.62 | -4,557.17 | -7,653.64 | -4,703.13 | -1,834.14 | -602.67 | -158.39 | -544.49 | 218.32 | -1,378.25 | -13.16 | -16.00 | -16.41 | -29.81 | -37.88 | -22.72 | -21.57 | -5.05 | -2.53 | -1.55 | 1.08 | |
| 417.50 | 1,087.50 | 182.48 | 15.40 | 60.59 | 118.13 | 547.23 | 610.27 | 226.39 | – | 194,690.27 | 20.06 | 43.54 | 37.23 | 38.46 | 115.60 | 227.68 | 100.21 | 47.61 | 0.94 | 0.65 | 0.50 | 1.58 | 0.00 | 2.70 | 0.76 | 0.18 | 0.16 | 0.00 | 0.09 | |
| 10,150.00 | 1,497.50 | 3,284.67 | 3,696.10 | 8,496.04 | 4,413.22 | 233.30 | -2,745.05 | -2,746.80 | -1,636.54 | -3,499.82 | 239.70 | -1,673.80 | -2,854.77 | -1,662.80 | -1,101.34 | -882.80 | -725.24 | 247.88 | 61.34 | 72.49 | 102.16 | 70.51 | 88.59 | 27.66 | 10.76 | 3.40 | 0.69 | 1.07 | 2.41 | |
| -6,765.00 | -9,110.00 | -6,021.90 | -3,336.76 | -2,493.20 | -2,766.65 | -4,292.94 | -3,216.31 | -3,834.23 | -2,830.82 | -694.16 | 1,698.35 | -995.51 | -237.99 | -549.10 | -478.48 | -205.14 | -0.05 | -82.92 | -9.72 | -9.90 | -14.29 | -30.83 | -34.42 | -9.81 | -17.73 | -5.55 | -1.75 | -1.42 | -1.27 | |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.